Latest filing published 01 Jul 2024 for Amarin CORP Plc\uk.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Thomas Charles Reilly: trading record in brief
Thomas Charles Reilly is a declared insider at 2 companies (finance chief); the most frequent names are Amarin CORP Plc\uk and Tvardi Therapeutics, Inc. In total, 18 filings cover trades dated from 24 August 2021 to 1 July 2024.
No open-market purchase appears, only 2 sales worth €45k. The rest of the record consists of 10 share grants and 6 option exercises.
On 1 July 2024 came the latest disclosure, a share grant for €5,275 in Amarin CORP Plc\uk. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thomas Charles Reilly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,667 sharesOrdinary SharesSEC:0000950170-24-079717:0
- 33,333 sharesOrdinary SharesSEC:0000950170-24-076300:0
- 44,933 sharesOrdinary SharesSEC:0000950170-24-010534:0
- 51,500 sharesOrdinary SharesSEC:0000950170-24-004305:0
- 16,667 sharesOrdinary SharesSEC:0000899243-23-016904:0
- 33,334 sharesOrdinary SharesSEC:0000899243-23-016257:0
- 2,044 shares@ US$11.3846.7% of flowCommon StockSEC:0001209191-22-016438:0
- 20,000 shares0Common StockSEC:0001209191-22-013992:0
- 11,170 shares0Common StockSEC:0001209191-21-070801:0
- 1,982 shares@ US$14.2053.3% of flowCommon StockSEC:0001209191-21-054303:0
- 5,334 shares0Common StockSEC:0001209191-21-053538:0
11 of 11 declarations
